Search
Patexia Research
Case number 1:24-cv-01189

ViiV Healthcare Company, et al v. Hetero USA Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Dec 11, 2024 14 CONSENT JUDGMENT Signed by Judge Mitchell S. Goldberg on 12/11/2024. (CASE CLOSED) (mpb) (Entered: 12/11/2024) (3)
Dec 11, 2024 15 FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (mpb) (Entered: 12/11/2024) (1)
Dec 9, 2024 13 PROPOSED CONSENT JUDGMENT by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 12/09/2024) (3)
Nov 22, 2024 12 SO ORDERED, re 11 STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to December 20, 2024 filed by Hetero Labs Limited Unit-III, Hetero USA Inc., Hetero Labs Limited. Signed by Judge Mitchell S. Goldberg on 11/21/2024. (mpb) (Entered: 11/22/2024) (2)
Nov 21, 2024 11 STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to December 20, 2024 - filed by Hetero USA Inc., Hetero Labs Limited Unit-III, Hetero Labs Limited. (Hitch, Cortlan) (Entered: 11/21/2024) (2)
Oct 30, 2024 N/A Case Assigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania, due to related cases. Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) (Entered: 10/30/2024) (0)
Oct 28, 2024 8 DECLARATION of Service for Hetero USA Inc. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 10/28/2024) (2)
Oct 28, 2024 9 DECLARATION of Service for Hetero Labs Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 10/28/2024) (2)
Oct 28, 2024 10 DECLARATION of Service for Hetero Labs Limited Unit-III by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 10/28/2024) (2)
Oct 23, 2024 1 COMPLAINT for Patent Infringement filed against Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc. (Filing fee $ 405, receipt number ADEDC-4530945) - filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 10/24/2024) (0)
Oct 23, 2024 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 10/24/2024) (3)
Oct 23, 2024 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/20/2024. Date of Expiration of Patent: .Thirty Month Stay Deadline: See Attached. (oam) Modified on 10/28/2024 (oam). (Entered: 10/24/2024) (2)
Oct 23, 2024 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (oam) (Entered: 10/24/2024) (1)
Oct 23, 2024 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (oam) Modified on 10/24/2024 (oam). (Entered: 10/24/2024) (1)
Oct 23, 2024 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited, Other Affiliate Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (oam) (Entered: 10/24/2024) (2)
Oct 23, 2024 7 Summons Issued as to Hetero Labs Limited on 10/23/2024; Hetero Labs Limited Unit-III on 10/23/2024; Hetero USA Inc. on 10/23/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(oam) (Entered: 10/24/2024) (0)
Menu